Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Exo Therapeutics is a small molecule drug discovery and development company.
A private biopharmaceutical company .
Primmune Therapeutics is a Biotechnology company.
Powering precision proteomics to enable to the earliest detection of disease.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe allergic diseases.
Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.
Enlaza Therapeutics is a biotechnology research company.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Abivax develops medicines that alter the body's natural immune system mechanisms.
Shenandoah Therapeutics is a biotechnology company.
Spyglass Pharma provides medicine for ophthalmic diseases.
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 16 different industry categories.
Among tracked funding rounds, Abivax received $747.5M in a Post Ipo Equity round. Samsara BioCapital's total known invested capital is $14.2B.
Samsara BioCapital's average investment size is $107.7M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include Allakos, ACELYRIN, DELFI Diagnostics, MiroBio, Chinook Therapeutics. These companies were founded in 2020 or later.